HCRT and schizophrenia: Several investigations have reported a role for orexin in psychiatric disorders such as mood disorders, anxiety disorders, and schizophrenia, and have suggested that orexin receptor antagonists, including suvorexant, may have therapeutic effects against these psychiatric disorders [20–22].